GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hugel Inc (XKRX:145020) » Definitions » Sale Of Investment

Hugel (XKRX:145020) Sale Of Investment : ₩1,105,780 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Hugel Sale Of Investment?

Hugel's sale of investment for the three months ended in Mar. 2024 was ₩385,492 Mil. It means Hugel gained ₩385,492 Mil from selling investments. Hugel's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,105,780 Mil.

Compared with last quarter (₩368,386 Mil in Dec. 2023 ), Hugel gained more money from selling investments in Mar. 2024 (₩385,492 Mil).


Hugel Sale Of Investment Historical Data

The historical data trend for Hugel's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hugel Sale Of Investment Chart

Hugel Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 962,044.53 43,553.08 216,872.29 181,300.00 838,869.93

Hugel Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118,582.76 239,095.68 112,805.86 368,385.63 385,492.43

Hugel Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,105,780 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hugel Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Hugel's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Hugel (XKRX:145020) Business Description

Traded in Other Exchanges
N/A
Address
61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon, Gangwon, KOR, 24206
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.

Hugel (XKRX:145020) Headlines

No Headlines